DIVA Laboratories, Ltd. (TPEX:4153)
Taiwan · Delayed Price · Currency is TWD 30.90
-0.75 (-2.37%)
Oct 8, 2026, 1:30 PM CST
DIVA Laboratories Market Cap
DIVA Laboratories has a market cap or net worth of 1.81 billion as of October 9, 2026. It is the 29,507th most valuable company in the world and the 1,737th biggest in Taiwan. Its market cap has decreased by 19.84% in one year.
Market Cap
1.81B
Enterprise Value
1.27B
Revenue
894.67M
Global Rank
Country Rank
#1,737 Taiwan
PE Ratio
18.96
ChartMarket Cap Chart
Since October 11, 2010, DIVA Laboratories's market cap has increased from 425.72M to 1.81B, an increase of 325.83%. That is a compound annual growth rate of 9.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.81B | -11.46% |
| Dec 31, 2025 | 2.05B | -8.76% |
| Dec 31, 2024 | 2.24B | 3.94% |
| Dec 29, 2023 | 2.16B | -9.25% |
| Dec 30, 2022 | 2.38B | 51.31% |
| Dec 30, 2021 | 1.57B | 8.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 2.96B |
| Genetics Generation Advancement | 1.09B |
| Puriblood Medical | 1.03B |
| Kim Forest Enterprise | 742.72M |
| Sofiva Genomics | 719.06M |
| TFBS Bioscience | 685.46M |
| Welgene Biotech | 400.83M |
| Pharmigene | 321.64M |